# REZZAYO
> **NDA217417** · New Drug Application · Sponsor: MUNDIPHARMA · Approved 2023-03-22
## Drug
- **FDA Application Number:** NDA217417
- **Application type:** New Drug Application
- **Brand name:** REZZAYO
- **Generic name:** REZAFUNGIN
- **Active ingredients:** REZAFUNGIN ACETATE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** MUNDIPHARMA
- **Manufacturer:** Melinta Therapeutics, LLC
- **First approval:** 2023-03-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217417)
---
*AI Analytics · CC0 1.0*